Marquez Dunlap (salarypull5)

Following the publication of this article, the authors regret that they did not make it clear which author was funded by the funding bodies. The information in the "Funding" part of the paper should therefore have been written as shown in follows (changes to the original text are highlighted in bold) "The present study was supported by the Young Scientists Fund of the National Natural Science, Foundation of China (to JL; grant no. 81502226) and the Guangdong Natural Science Foundation (to JL; grant no. 2014A030313038)." The authors apologize to the readership of the Journal for any inconvenience caused. [the original article was published in International Journal of Oncology 53 855‑865, 2018; DOI 10.3892/ijo.2018.4437].Following the publication of this article, an interested reader drew to the authors' attention that, in Fig. 6B on p. 706, various of the data panels appeared to show overlapping data. After having carefully re‑examined the manuscript, raw data and laboratory records, the authors were able to identify the correct data for the figure concerned. Essentially, some of the data panels in Fig. 6 had been erroneously selected from photographs taken of the same data, but with different fields of view. In addition, the authors repeated some of the contentious experiments and obtained similar results, thereby corroborating the results and conclusions reported in this study. Therefore, the errors made with the assembly of Fig. 6 did not have an adverse bearing on the overall conclusions reported in the study. A revised version of Fig. 6, presenting the correct data for Fig. 6B, is shown on the next page. The authors are grateful to the Editor of International Journal of Oncology for allowing them the opportunity to publish this Corrigendum, and all of the authors agree to the publication of this Corrigendum. The authors sincerely apologize for this mistake, and apologize to the readership of the Journal for any inconvenience caused. [the original article was published in International Journal of Oncology 49 700‑708, 2016; DOI 10.3892/ijo.2016.3547].Walnut (Juglans regia L.) is considered to be a 'superfood' for its multiple protective actions on human health. Walnut extracts have proven antitumor activity in different cancer cell lines. However, the efficacy of septum extract against glioblastoma has still not been investigated. Glioblastoma is the most difficult type of brain cancer to treat. The standard therapy, based on temozolomide, causes several side effects, including neutropenia and lymphocytopenia, which often favor the onset of opportunistic infections. In the present study, the chemical profile of the Sicilian walnut septum ethanolic extract was analyzed using high‑performance liquid chromatography (HPLC)‑diode array detection and HPLC‑electrospray ionization tandem mass spectrometry. The potential cytostatic activity of the extract against the human A172 glioblastoma cell line was investigated and the results showed that the extract could decrease cancer cell proliferation and migration. Using cytofluorimetric analyses and caspase‑3 assays, the pro‑apoptotic action of walnut extract was demonstrated. Furthermore, the evaluation of the antibacterial activity highlighted the efficacy of the extract in reducing Gram‑positive and Gram‑negative bacterial growth, most of which were resistant to the antibiotic, ciprofloxacin. Finally, Prediction of Activity Spectra for Substances analysis showed the predicted antitumor and antibacterial activity of HPLC detected compounds. The promising results could provide novel perspective in the field of chemotherapeutic co‑adjuvants.Subsequently to the publication of the above article, an interested reader drew to the authors' attention that, in Fig. 1B on p. 1552, the MCF‑7 and T24, and the A549 and ScaBER data panels, respectively, appeared to be strikingly similar. After having re‑examined the original data, the authors have realized that these pairings of data panels were